Results 111 to 120 of about 20,049 (168)

Differentiating Benign from Malignant Adrenocortical Tumors by a Single Morphological Parameter-a Clinicopathological Study on 837 Adrenocortical Neoplasias. [PDF]

Indian J Surg Oncol, 2020
Walz MK, Metz KA, Theurer S, Myland C, Alesina PF, Schmid KW.   +5 more
europepmc   +1 more source

Clinical, Genetic, and Prognostic Features of Adrenocortical Tumors in Children: A 10-Year Single-Center Experience. [PDF]

Front Oncol, 2020
Miele E, Di Giannatale A, Crocoli A, Cozza R, Serra A, Castellano A, Cacchione A, Cefalo MG, Alaggio R, De Pasquale MD.   +9 more
europepmc   +1 more source

Low PRKAB2 Expression Is Associated with Poor Outcomes in Pediatric Adrenocortical Tumors, and Treatment with Rottlerin Increases the PRKAB2 Level and Inhibits Tumorigenic Aspects in the NCI-H295R Adrenocortical Cancer Cell Line. [PDF]

Cancers (Basel)
Xavier AET, Veronez LC, Nagano LFP, Correa CAP, Baroni M, Ramos MS, Queiroz RGP, Fernandes Molina CA, Yunes JA, Brandalise SR, Antonini SAR, Tone LG, Valera ET, Scrideli CA.   +13 more
europepmc   +1 more source

GnRH antagonist treatment of malignant adrenocortical tumors. [PDF]

Endocr Relat Cancer, 2019
Doroszko M, Chrusciel M, Stelmaszewska J, Slezak T, Anisimowicz S, Plöckinger U, Quinkler M, Bonomi M, Wolczynski S, Huhtaniemi I, Toppari J, Rahman NA.   +11 more
europepmc   +1 more source